Hikma Pharmaceuticals Share Price (HIK)

1,821.00 -24.00 (-1.30%) delayed: 8:23PM BST
Bid price 1,818.00 Open price 1,837.00
Ask price 1,824.00 Prev close 1,821.00
High price 1,847.52 Spread 0.33%
Low price 1,817.00 Volume 475,393

Register now for FREE live Hikma Pharmaceuticals share prices, Hikma Pharmaceuticals stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Hikma Pharmaceuticals Level 2 Data, indepth research tools and investor commentary for Hikma Pharmaceuticals (HIK) and other London Stock Exchange equities.

Hikma Pharmaceuticals Share Price Chart

Advanced Charts >>

Register now for FREE Hikma Pharmaceuticals share price charts

Hikma Pharmaceuticals Share Price Information

Name Hikma Pharmaceuticals Epic HIK
Sector Pharmaceuticals & Biotechnology ISIN GB00B0LCW083
Activites Hima Pharmaceuticals plc is a multinational pharmaceutical group focused on developing, manufacturing and marketing a broad range of both branded and non-branded generic and in-licensed pharmaceutical products. Index FTSE 100

Hikma Pharmaceuticals Key Numbers

Latest Share Price (p) 1,821.00 Net Gearing (%) 41.19
Market Capitalisation (£m) 4,427.61 Gross Gearing (%) 44.74
Shares in issue (m) 239.98 Debt Ratio 30.02
P/E Ratio 27.74 Debt-to-Equity Ratio 0.53
Total dividends per share (p) 33.00 Assets / Equity Ratio 1.81
Dividend Yield (%) 1.15 Price to book value 1.84
Dividend cover (x) 3.19 ROCE (%) 6.10
Earning per share (p) 66.50 EPS Growth (%) -47.47
52 week high / low 2,703.00 / 1,575.00 DPS Growth (%) 3.13

Hikma Pharmaceuticals Director Deals

Dec.Date Type Director Pos No. of Shares
20/12/2016 BUY Ali Al-Husry NED 140,730
20/12/2016 BUY Mazen Darwazah ED 140,730
20/12/2016 BUY Said Darwazah CH 140,730
13/12/2016 BUY Ali Al-Husry NED 50,000
13/12/2016 BUY Mazen Darwazah ED 50,000

More Hikma Pharmaceuticals Director Deals >>

Hikma Pharmaceuticals Company News

08:58 13/04/2017

Director/PDMR Shareholding

RNS Number : 4403C Hikma Pharmaceuticals Plc 13 April 2017     Notification and public disclosure of transactions by persons discharging managerial responsibilities 1 Details of the person discharging managerial responsibilities / person closely associated...

08:43 13/04/2017

Director/PDMR Shareholding

RNS Number : 4388C Hikma Pharmaceuticals Plc 13 April 2017     Hikma Pharmaceuticals PLC - EIP Awards   LONDON, 13 April 2017: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) announces that the Remuneration Committee has made the following conditional...

08:42 13/04/2017

Director/PDMR Shareholding

RNS Number : 4387C Hikma Pharmaceuticals Plc 13 April 2017     Hikma Pharmaceuticals PLC - EIP Awards   LONDON, 13 April 2017: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) announces that the Remuneration Committee has made the following conditional...

More Hikma Pharmaceuticals Company News >>

Register now for FREE Hikma Pharmaceuticals company news

Hikma Pharmaceuticals Share Price Discussions

more than 1 year ago

Hikma Pharmaceuticals (HIK)

Floated in London last November at 290p (FTSE-250). Company website www.hikma.com Develops, manufactures and markets branded and non-branded generic pharmaceuticals, as well as in-licensed, patented pharmaceuticals Geographic markets: USA, Europe and the Middle East & North Africa...

Register now for FREE Hikma Pharmaceuticals share price discussions